Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CA12 inhibitors(carbonic anhydrase 12 inhibitors), CAIX inhibitors(Carbonic anhydrase IX inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H30O4 |
InChIKeyFCWYNTDTQPCVPG-XLRKYUMYSA-N |
CAS Registry57525-77-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma | Preclinical | France | 19 May 2025 | |
| Melanoma | Preclinical | France | 19 May 2025 |





